Publication | Closed Access

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?

Hematological MalignancyMedicineHematologySitu Hybridization AnalysisPathologyMyeloid NeoplasiaFluorescent In Situ HybridizationLaboratory MedicineRadiation OncologyMyelodysplastic SyndromesNovel Imaging MethodRadiologyHealth Sciences